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Paracrine cellular senescence exacerbates biliary
injury and impairs regeneration
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Juan-Carlos Acosta 4, Luke Boulter 5 & Stuart J. Forbes1
Cellular senescence is a mechanism that provides an irreversible barrier to cell cycle pro-
gression to prevent undesired proliferation. However, under pathological circumstances,
senescence can adversely affect organ function, viability and regeneration. We have devel-
oped a mouse model of biliary senescence, based on the conditional deletion of Mdm2 in bile
ducts under the control of the Krt19 promoter, that exhibits features of biliary disease. Here
we report that senescent cholangiocytes induce profound alterations in the cellular and
signalling microenvironment, with recruitment of myoﬁbroblasts and macrophages causing
collagen deposition, TGFβ production and induction of senescence in surrounding cho-
langiocytes and hepatocytes. Finally, we study how inhibition of TGFβ-signalling disrupts the
transmission of senescence and restores liver function. We identify cellular senescence as a
detrimental mechanism in the development of biliary injury. Our results identify TGFβ as a
potential therapeutic target to limit senescence-dependent aggravation in human
cholangiopathies.
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Primary sclerosing cholangitis (PSC) and primary biliarycholangitis (PBC) are the most prevalent type of cho-langiopathies, a diverse group of genetic and acquired dis-
orders that affect the biliary population of the liver1–3. PSC/PBC
have variable prognoses but frequently evolve into end-stage liver
disease, with limited treatment options.
The aetiologies remain unclear, although a role of cellular
senescence in the development of PSC/PBC has been
suggested4–8. Senescence is an irreversible cell cycle arrest, driven
by dominant cell-cycle inhibitors and characterized by changes in
morphology, increased lysosomal content9, expression of DNA
damage response (DDR) factors10, and the activation of the
senescence-associated secretory phenotype (SASP)11,12.
The SASP is a pro-inﬂammatory response that activates and
reinforces the senescent phenotype in the surrounding cells12,
modulates ﬁbrosis13 and promotes regeneration11,14. The SASP is
composed by a variable set of secreted cytokines and chemokines,
responsible for the beneﬁcial and deleterious effects of senescence
within the tissue11–18. TGFβ, a cytokine involved in proliferation,
migration, cellular differentiation and cell cycle regulation is a cri-
tical element for the establishment of paracrine senescence through
the SASP. TGFβ induces and maintains paracrine senescence
through a mechanism that generates reactive oxygen species and
DDR12,19 and by inducing p21 expression in a p53 independent
manner through the regulation of p27 and p1511,19–21.
However, despite a number of studies suggesting a potential
link between senescence and biliary disease4–8, it has not been
shown whether senescence is actually a driver of the damage
rather than solely a consequence8. We have therefore investigated
the relationship between senescence and biliary disease, focusing
on SASP-related mechanisms to explain part of the pathophy-
siology of PSC/PBC.
Here, we present a model of biliary disease, based on the
conditional deletion of Mdm2 in bile ducts under the control of
the Krt19 cholangiocyte promoter. In this model, senescent
cholangiocytes induce profound alterations in the cellular and
signalling microenvironment, with recruitment of myoﬁbroblasts
and macrophages causing collagen deposition, TGFβ production
and induction of senescence in surrounding cholangiocytes and
hepatocytes. Finally, we study how inhibition of TGFβ-signalling
disrupts the transmission of senescence and restores liver func-
tion. In doing so we provide potential opportunities for therapies
based on the disruption of the TGFβ-dependent SASP response.
Results
Cellular senescence is an intrinsic feature of PSC/PBC.
Assessment of PSC/PBC human biopsies corroborate the pre-
sence of previously described senescence-factors like p214
(Fig. 1a). p21 is also expressed in some periportal hepatocytes
(Fig. 1a).
Other senescence markers such as p168 (Fig. 1b), DCR211
(Fig. 1c), γH2A.X8 (Fig. 1d) and p2711 (Fig. 1e) are also present in
Keratin 19 (K19)-expressing cholangiocytes. Again, some peri-
portal hepatocytes express markers of senescence such as γH2A.X
and DCR2 (Supplementary Fig. 1a, b).
PSC and PBC are clinically characterized by increased ductular
response (Supplementary Fig. 1c), apoptotic bile ducts (Supple-
mentary Fig. 1d)4, extensive ﬁbrotic areas (Supplementary Fig. 1e)
and copper deposition (Supplementary Fig. 1f), all important
factors for the evolution of the disease1–3.
Deletion of Mdm2 results in p21-driven senescence. To test
whether senescence could be a pathological driver of such cho-
langiopathies, we developed a model in which biliary senescence
is triggered in cholangiocytes using a tamoxifen-inducible K19-
Mdm2ﬂox/ﬂoxtdTomLSL mice (Fig. 2a).
Murine Double Minute 2 (Mdm2) is a key negative regulator of
p53, that positively regulates p21 expression. Therefore,
cholangiocyte-speciﬁc (via Keratin19CreERT) deletion of Mdm2
results in p21 expression in bile ducts (Fig. 2b and Supplementary
Fig. 2 a, b).
Low occurrence of proliferating p53-positive cholangiocytes
(0.1% Mean ± SEM) (Fig. 2c and Supplementary Fig. 2c) suggests
that activation of the p53-p21 axis initiates cell cycle arrest.
Expression of other senescence markers like 53BP1, γH2A.X and
DCR2 (Fig. 2d) suggests the occurrence of cellular senescence in
cholangiocytes. Furthermore, some hepatocytes also express
53BP1, γH2A.X and DCR2 (Fig. 2d) while maintaining Mdm2
expression (Supplementary Fig. 2d). This suggests that the
presence of senescent hepatocytes is a consequence of paracrine
activity from the cholangiocytes and not due to Cre-
recombination or spontaneous loss of Mdm2 in hepatocytes.
Cre activity in senescent cholangiocytes can be traced by the
expression of tdTomato (tdTom) (Fig. 2e), which is restricted to
cholangiocytes indicating that Cre activity is cholangiocyte
speciﬁc. The percentage of recombined tdTom-positive cells that
proliferate is very low and does not signiﬁcantly vary over the
course of 90 days, suggesting that the cell cycle arrest remains
unaltered (Supplementary Fig. 2e). Furthermore, tdTom expres-
sion colocalizes with p53 in cholangiocytes (Fig. 2f), suggesting
that p53 expression is directly associated with tdTom presence in
cholangiocytes.
The percentage of tdTom-positive cells remain unchanged in
the liver 90 days post-induction (Supplementary Fig. 3a),
accompanied by ductular reaction (Supplementary Fig. 3b, c).
Over the course of 90 days, we observed liver disease progression
as evidenced by changes in liver biochemistry, including alanine
aminotransferase, aspartate aminotransferase and bilirubin (Sup-
plementary Fig. 3d). We did not observe ductopenia (Supple-
mentary Fig. 3e).
Our model also displays p16 in cholangiocytes and some
hepatocytes (Supplementary Fig. 4a), suggesting that senescence
expands from cholangiocytes towards the parenchyma through
paracrine signalling.
Furthermore, K19-Mdm2ﬂox/ﬂoxtdTomLSL mice display large
mononuclear inﬁltrates (Supplementary Fig. 4b) which were
identiﬁed as F4/80-positive macrophages (Supplementary Fig. 4c),
suggesting the presence of cholangiocyte-dependent paracrine
signalling. Twenty-one days after induction, apoptosis occurs in
the bile ducts (Supplementary Fig. 4d), which was previously
described in human PSC/PBC4 and could potentially amplify the
effect of senescence to exacerbate biliary injury.
We found increased intensity of αSMA-positive cells surround-
ing the senescent cholangiocytes (Fig. 2g, h and Supplementary
Fig. 5a, b, c). We also found increased collagen deposition
(Fig. 2i) that progressively accumulates over the course of 90 days
(Supplementary Fig. 5d).
As our model induces cellular senescence in the K19-positive
epithelia, we examined other organs (kidney and gut) for markers
of cellular senescence such as p16 (Supplementary Fig. 6a). Both
kidney and gut presented increased levels of ﬁbrosis over the
course of 90 days (Supplementary Fig. 6b). We did not ﬁnd
evidence of the involvement of mesothelial cells in our model
(Supplementary Fig. 6c).
We also compared the senescence response in Mdm2ﬂox/ﬂox
models with different promoters (see Supplementary Fig. 7a for
K19-Mdm2ﬂox/ﬂoxtdTomLSL model, and Supplementary Fig. 7b
for OPN-Mdm2ﬂox/ﬂoxYFP, respectively), both targeting cholan-
giocytes22,23. Both models present similar levels of recombination
(Supplementary Fig. 7c) and induction of senescence in
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Fig. 1 Cellular senescence is an intrinsic characteristic of PBC/PSC. Explanted human livers diagnosed as Normal, PSC and PBC respectively (series of N= 7 per
group). a Immunohistochemical detection of p21 in bile ducts. Far right, digital magniﬁcation of p21-positive hepatocytes (top) and cholangiocytes (bottom). b
PSC and PBC show p16 expression (red) in cholangiocytes (green). Far right, quantiﬁcation of p16 in K19-positive cholangiocytes. Median age of each of the
groups is also included in this ﬁgure. c PSC and PBC show DCR2 expression (green) in cholangiocytes (red). Far right, quantiﬁcation. d PSC and PBC show γH2A.
X expression (green) in cholangiocytes (red). Far right, quantiﬁcation. e Immunohistochemical detection of p27 increases in PSC and PBC compared to Normal
Liver. ** denotes p <0.01, *** denotes p <0.001, **** denotes p <0.0001 (Mean ± SEM). ANOVA, Sidak’s multiple comparisons test. Scale bars= 50 µm
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Fig. 2 Cholangiocyte-speciﬁc deletion of Mdm2 results in p21-driven cellular senescence. a Schematic explanation of the model: K19CreERT promoter is
used to ﬂox out Mdm2 in cholangiocytes. Upon tamoxifen administration, Cre recombinase is activated and Mdm2 is cleaved. The STOP sequence
upstream tdTom reporter sequence is also ﬂoxed out making the identiﬁcation of primary senescent events traceable through tdTom expression. b
Increased levels of p21 in bile ducts 2 days after tamoxifen administration. Mouse data is presented at day 2 after ﬁnal tamoxifen administration (N= 6 per
group). (Left) K19Cre-positive mice without tamoxifen injection. (Center) K19Cre-negative mice after tamoxifen injection. (Right) K19Cre-positive mice
after tamoxifen injection. c Cell-cycle-arrested cells do not proliferate. 0.1% (Mean ± SEM) of cholangiocytes co-express p53 (red) and Ki67 (green) 2 days
after tamoxifen administration. d From top to bottom: 53BP1, γH2A.X and DCR2 (red) in K19-positive cholangiocytes (green). Notice the presence of
53BP1-positive, γH2A.X-positive and DCR2-positive hepatocytes in Cre+ +TM group. Bottom panel: Cre− +TM shows some DCR-positive hepatocytes
(white arrowheads). e Recombined K19-positive cholangiocytes (green) can be traced by means of tdTom expression (red). f tdTom (red) co-localizes with
p53 (green) in bile ducts. g Increased intensity of αSMA-positive cells (green) contiguous to tdTom-positive senescent-cholangiocytes (red) compared
with tdTom-negative bile ducts at day 21 after induction N= 6. For an explanation about how this result was acquired, refer to Supplementary Fig. 5. h
Increased total percentage of αSMA-positive cells in the Cre+ +TM group at day 21. i Increased deposition of collagen measured by PicroSirius Red (PiSR)
at 21 days after tamoxifen induction. Right, quantiﬁcation. ** denotes p < 0.01 (Mean ± SEM), Student’s ttest. Scale bars= 50 µm
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Fig. 3 Paracrine senescence in the model is TGFβ-dependent. Mouse data is presented at day 2 after ﬁnal tamoxifen administration (N= 6 per group).
(Left) K19Cre-positive mice without tamoxifen injection. (Center) K19Cre-negative mice after tamoxifen injection. (Right) K19Cre-positive mice after
tamoxifen injection. a p53 (red, indicative of primary senescence events in the cholangiocytes) and p21 (green) co-localize in the bile ducts. However, p21-
positive p53-negative cholangiocytes were observed. b p21 (green) co-localizes with HNF4α-positive hepatocytes (red). c p27 (green) colocalizes with
p53-positive cholangiocytes (red). p27 is expressed in cholangiocytes and hepatocytes in a paracrine manner. d p27 (green) co-localizes with HNF4α-
positive hepatocytes (red). e Markers of senescence (such as 53BP1, H2A.X and DCR2, in red) are expressed in cholangiocytes and liver parenchyma,
while expression of p53 (green) is restricted to the cholangiocytes. Single channels for this ﬁgure are provided in Supplementary Fig. 8a. Scale bars= 50
µm. f qRT-PCR analysis of Tgfb1 in the isolated bile ducts of Cre− +TM (N= 5) and induced Cre+ +TM (N= 6) K19-Mdm2ﬂox/ﬂoxtdTomLSL mice day 2
after induction. *** denotes p < 0.005 (Mean ± SEM). Mann−Whitney test. g Analysis of common SASP’s factors by qRT-PCR (from left to right, Tgfbr1,
Tgfbr2, Nfkb, Il1a and Il6). * denotes p < 0.05, ** p < 0.01 (Mean ± SEM). Mann−Whitney test. h Western blot of phospho-NF-κB-p65 and pSmad2/3. Each
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western blot densitometry quantiﬁcation (normalized to bActin control) show increased expression of NF-κBp-65 and pSmad2/3 after induction of the
model. * denotes p < 0.05 (Mean ± SEM). Mann−Whitney test. i qRT-PCR of Nfkb in hepatocytes isolated from Cre− and Cre+ K19-Mdm2ﬂox/
ﬂoxtdTomLSL mice at day 2 after last tamoxifen administration (N= 5-6 per group). ** denotes p < 0.01 (Mean ± SEM). Mann−Whitney test
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cholangiocytes (Supplementary Fig. 7d). Furthermore, while
expression of the tdTom or YFP is restricted to cholangiocytes,
scattered expression of p21 can be seen in the parenchyma
(Supplementary Fig. 7e), suggesting that there is a mechanism that
induces senescence in a paracrine manner. Furthermore, we found
p21-positive, p53-negative cholangiocytes (Supplementary Fig. 7f)
in both models, suggesting a non-autonomous activation of p21,
independent of the activation of p53 after Cre recombination.
Altogether, these results partially resemble the main character-
istics of clinical PSC/PBC1–3 and suggest that senescent
cholangiocytes generate a local microenvironment that induces
paracrine senescence in the surrounding hepatocytes, promotes
macrophages recruitment and induces collagen deposition.
Paracrine senescence in the model is TGFβ-dependent. Fol-
lowing Cre activation, p21-positive, p53-negative cholangiocytes
were observed in bile ducts (Fig. 3a). Furthermore, while p53
expression is restricted to cholangiocytes (Fig. 3a), we detected
p21-positive HNF4α-positive hepatocytes (Fig. 3b).
p27, a direct target of transforming growth factor β (TGFβ)
11,19–21, is also expressed in cholangiocytes and hepatocytes in a
similar pattern to p21 (Fig. 3c, d).
These senescent hepatocytes also express other senescence
markers (53BP1, γH2A.X and DCR2), while p53 is restricted to
the bile ducts (Fig. 3e and Supplementary Fig. 8a and b). These
observations indicate that senescence triggered in hepatocytes is
non-autonomous and p53-independent. This suggests the
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presence of a cholangiocyte-derived paracrine mediator that
targets the liver parenchyma. To test this hypothesis, we focused
into SASP signalling.
One of the most notable components of the SASP response is
TGFβ. TGFβ can induce senescence in a paracrine manner, via a
mechanism that generates reactive oxygen species and DDR11,19–
21,24,25. TGFβ blocks the progression of the cell cycle at the
restriction point in late G1 phase by transcriptional activation of
cyclin-dependent kinase inhibitors (p21, p27 and p15,) through
the SMAD complex11,19–21,24,25.
We isolated bile ducts and hepatocytes from K19-Mdm2ﬂox/ﬂox
tdTomLSL mice after the induction of senescence. As expected,
isolated bile ducts express high levels of K19 and low levels of
HNF4a, as opposed to the hepatocytes (Supplementary Fig. 9a).
Furthermore, bile ducts from induced mice present signiﬁcantly
increased mRNAs levels of cdkn1a (p21), cdkn1b (p27) and
cdkn2a (p16) (Supplementary Fig. 9b).
The mRNAs encoding SASP proteins revealed a signiﬁcant
increased expression of Tgfb1 in bile ducts (p= 0.0007) (Fig. 3f).
After senescence, isolated bile ducts also exhibit increased gene
expression of Tgfbr1 (p= 0.0023) and Tgfbr2 (p= 0.0047)
(Fig. 3g). Other SASP’s factors were also signiﬁcantly increased
in bile ducts, such as Nfkb (p= 0.0132) and Il1a (p= 0.0160)
while there is a trend to increase in Il6 level (p= 0.1708) (Fig. 3g
and Supplementary Fig. 9c).
Western blot analysis also revealed increased protein levels of
pSmad2/3, suggesting a direct functional role for TGFβ in the
activation of the SMAD complex (Fig. 3h).
Increased levels of phospho-NF-κB-p65, a master regulator of
the SASP26, at protein (Fig. 3h) and gene level (see Fig. 3g)
suggest a robust activation of the SASP in bile ducts. Interestingly,
we observed upregulation of Nfkb in hepatocytes after Cre
activation (p= 0.0010) (Fig. 3i). Isolated hepatocytes also
signiﬁcantly upregulate Tgfbr1 (p= 0.0043) and Tgfbr2 (p=
0.0173) (Supplementary Fig. 9d).
Furthermore, in situ hybridization (ISH) for Tgfb1-ligand also
suggests that TGFb is produced by cholangiocytes and surround-
ing hepatocytes (Supplementary Fig. 9e). These results suggest a
potential mechanism of paracrine senescence activation triggered
by the SASP in the parenchyma.
The above observations indicate that the K19-Mdm2ﬂox/ﬂox
tdTomLSL model robustly establishes senescence in cholangio-
cytes and induces a TGFβ-dependent SASP response in the
parenchyma.
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Cellular senescence aggravates biliary injury. To test if cho-
langiocyte senescence affects the outcome of biliary injury, we
administered 1 week of diethoxycarbonyl-1,4-dihydro-collidine
(DDC) diet to the K19-Mdm2ﬂox/ﬂoxtdTomLSL model (Fig. 4a).
The DDC diet has been previously used to induce features of
PSC/PBC27 but, up to date, the effects of senescence in this model
are not known.
Following DDC administration, there is a signiﬁcant increase
of serum transaminases in the tamoxifen-injected group (Fig. 4b).
Decrease in cholangiocyte proliferation (Fig. 4c) and increased
p21-positive cholangiocytes (Fig. 4d) can be observed in
concurrence with decreased total liver proliferation (Fig. 4e).
Increased number of p21-positive hepatocytes (Fig. 4f) and p27-
expressing cells can be seen in the tamoxifen-injected group
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(Fig. 4g), supporting the hypothesis that senescence spreads from
cholangiocytes to the rest of the liver. Further comparison
between control groups (healthy wild-type mice, wild-type mice
on DDC diet and the uninduced K19-Mdm2ﬂox/ﬂoxtdTomLSL
model) can be found in Supplementary Fig. 10a-e.
Furthermore, increased αSMA-positive cells proximal to
tdTom-positive cholangiocytes (Fig. 4h) and collagen deposition
(Fig. 4i) suggest that senescent cells generate a local microenvir-
onment that results in ﬁbrogenesis. Increased number of F4/80-
positive macrophages (Fig. 4j) can also be observed in the
tamoxifen-injected group. We did not ﬁnd signiﬁcant differences
in the total number of K19-positive cells between the vehicle and
tamoxifen-injected group after DDC diet (Supplementary
Fig. 10f).
These data altogether suggest that senescence can aggravate
biliary injury by spreading to the parenchyma.
Cellular senescence impairs liver parenchyma regeneration. To
test whether the effects of paracrine senescence upon the hepa-
tocytes affect the regenerative capacity of the liver, we induced
senescence in cholangiocytes in the K19-Mdm2ﬂox/ﬂoxtdTomLSL
model and tested hepatocyte regenerative capacity with 70%
partial hepatectomy (PH), a well-described model of hepatocyte-
mediated liver regeneration (Fig. 5a)28.
In the livers subjected to senescence and PH, compensatory
hypertrophy of the remaining lobes is reduced (Fig. 5b).
Decreased proliferation (Fig. 5c and Supplementary Fig. 11a)
and increased p21-positive hepatocytes (Fig. 5d and Supplemen-
tary Fig. 11b) occur in the senescent group. We observed
increased p27 expression (Fig. 5e) suggesting an active role of
TGFβ-dependent SASP mechanism in the parenchyma.
One week after PH there was a marked decrease in survival in
the senescent group (Fig. 5f), suggesting that the livers subjected
to cholangiocyte senescence and SASP effects are unable to
compensate the loss of liver tissue. We did not ﬁnd evidence of
the involvement of mesothelial cells in our model (Supplementary
Fig. 11d).
These results suggest that cholangiocyte senescence impairs the
regenerative response of the liver parenchyma. This could
potentially account for the loss of hepatocyte function seen in
human PSC/PBC patients.
Senescence is transmitted in vitro through TGFβ. To test
whether transmission of senescence from cholangiocytes to the
surrounding hepatocytes is TGFβ-dependent, we generated an
in vitro model based on the induction of paracrine senescence in
culture expanded biliary cells derived from normal mouse liver as
previously described29.
As previously shown by Tabibian and collaborators, N-Ras
activation is an intrinsic characteristic of senescent cholangiocytes
in PSC8. We generated a system of paracrine senescence based
upon N-RAS activation (Fig. 6). Brieﬂy, we added conditioned
media from senescent cells (CM-SASP) to our biliary cells
(Fig. 6a). CM-SASP is produced by IMR90 ER:RAS cells in which
senescence is induced by means of the activation of a RAS-
chimaeric fusion protein12.
CM-SASP induced senescence in the biliary cells, causing
growth arrest (Fig. 6b), with increased mRNA levels of cdkn1a,
cdkn1b and cdkn2a (Fig. 6c). Altered cell morphology (Fig. 6d)
and upregulated expression of several senescent markers with
reduced BrdU incorporation (Fig. 6e, f) are observed.
With the same method, we induced senescence in biliary cells,
withdrew the CM and then added YFP-positive biliary cells
(Fig. 7a). This allows the assessment of the paracrine senescence
transmission from the senescent biliary cells to the YFP-biliary
cells. Quantiﬁcations in the YFP-biliary cells showed increased
senescent markers and decreased BrdU incorporation, demon-
strating that senescence can be transmitted in a paracrine manner
in vitro (Fig. 7b).
In order to inhibit the transmission of paracrine senescence, we
blocked TGFβ signalling pathway and assessed the same markers
of senescence in the YFP-biliary cells. To that purpose, we used a
small molecule that targets the TGFβ receptors ALK4, ALK5 and
ALK730 (LY2157299), effectively blocking TGFβ signalling path-
way (Fig. 7c).
Addition of LY2157299 caused a signiﬁcant reduction of
paracrine senescence in the YFP-biliary cells (Fig. 7d and
Supplementary Fig. 12a, b), without altering the number of
primary senescent biliary cells (Supplementary Fig. 12c). These
results accentuate the importance of TGFβ in the transmission of
paracrine senescence, and offers a potential approach for the
inhibition of paracrine senescence in biliary disease.
Finally, we investigated whether macrophages are able to clear
senescent biliary cells. We established an in vitro system in which
senescent YFP-biliary cells were co-cultured with bone marrow-
derived macrophages artiﬁcially labelled with 647-Cell Mask
(647-BMDM). Interaction between the senescent YFP-biliary cells
and 647-BMDM can be observed in the co-culture system
(Supplementary Fig. 13a-h). The number of senescent biliary cells
signiﬁcantly decreased after 72 h when cultured with 647-BMDM
(Supplementary Fig. 13h), suggesting that BMDMs can target and
eliminate senescent biliary cells.
Inhibition of TGFβ in vivo improves liver function. We
investigated the therapeutic effect of TGFβ signalling disruption
during paracrine senescence in the DDC biliary disease model.
LY2157299 treatment (Fig. 8a) resulted in decreased number of
p21-positive cholangiocytes (Fig. 8b, c), a signiﬁcant reduction of
total p21 (Fig. 8d) and p27-expressing cells in the liver (Fig. 8e),
reﬂecting a decrease in the paracrine senescence response. The
number of primary senescent cholangiocytes (tdTom-positive)
remain unaltered (Fig. 8f), proving that primary senescence is not
affected by the administration of LY2157299.
Administration of LY2157299 in the K19-Mdm2ﬂox/ﬂoxtd-
TomLSL model prior to DDC diet (Fig. 8g) resulted in improved
liver function as shown by decreased serum transaminases
Fig. 6 CM-SASP induces senescence in a paracrine manner. a Schematic representation of the experiment. Biliary cells are cultured with SASP-conditioned
media (CM-SASP) and Control-conditioned media (CM-Ctrol). After 1 week, different markers of senescence were evaluated. b Number of total Ctrol-
treated biliary cells increase (suggesting that they continue proliferating). Total number of CM-SASP-treated biliary cells plateau, indicative of an impaired
proliferative response. **** denotes p < 0.0001 (Mean ± SEM). Mann−Whitney test. N= 7–8 biological replicates. c qRT-PCR shows a signiﬁcant increased
expression of cdkn1a (p21), cdkn1b (p27) and cdkn2a (p16) in the CM-SASP-treated biliary cells at day 7. * denotes p < 0.05 (Mean ± SEM). Mann−Whitney
test. N= 4 biological replicates. d Morphological changes observed in the cell cultures. CM-SASP-treated biliary cells become ﬂatter, larger and their
content is vacuolized. e Increased SA-βGal (red) expression in CM-SASP-treated biliary cells with decreased BrdU incorporation (green). Far right, total
percentage of SA-βGal or BrdU per DAPI-positive nuclei per ﬁeld. f Increased expression of different senescence markers in CM-SASP-treated biliary cells
compared with the CM-Ctrol-treated biliary cells. Below, total percentage of those markers per DAPI-positive nuclei. * denotes p < 0.05 (Mean ± SEM).
Mann−Whitney test. N= 4 biological replicates. Scale bars= 50 µm
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(Fig. 8h), increased number of proliferating cholangiocytes
(Fig. 8i) and increased liver proliferation (Fig. 8j). These results
correlate with a trend towards decrease in p27-positive cells (p=
0.0952; Fig. 8k), and reduced p21-positive and p16-positive
hepatocytes (Fig. 8l). We also observed a decrease in collagen
deposition (Fig. 8m) that may reﬂect a decrease in the ﬁbrogenic
response, and a trend towards decreased numbers of F4/80
macrophages (p= 0.1508; Fig. 8n).
Discussion
Cellular senescence is the permanent cell-cycle arrest related to
the process of ageing31 and has recently been described as a
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tumour-preventive mechanism32. In the liver, it has been asso-
ciated with cholangiocytes in end-stage liver disease33, identiﬁed
in hepatocytes in cirrhotic livers34,35, and described as a
mechanism to control hepatic stellate cell-mediated
ﬁbrogenesis13.
In biliary disease, senescence has proved to be an essential
characteristic of PSC/PBC: Sasaki et al. described the presence of
senescent cells in human PSC/PBC5,6, and Tabibian et al. sug-
gested the importance of N-Ras-induced senescence and its
paracrine effects in PSC8. Furthermore, the Mdr2 knock-out
mouse model exhibits high levels of p16-dependent cholangiocyte
senescence36, and is characterized by the spontaneous develop-
ment of cholangitis and ‘onion skin’ periductal ﬁbrosis, suggest-
ing a potential contribution of senescence to the development of
biliary disease. These observations highlight the importance of
cholangiocyte-senescence in biliary disease.
We have developed a highly efﬁcient model to induce senes-
cence speciﬁcally in cholangiocytes, partially resembling human
biliary disease. This model offers the advantages of conditional
activation and can be used as a tool to study the mechanisms of
biliary senescence in the liver. The presence of senescent cho-
langiocytes in this model promotes ductular reaction, increases
deposition of collagen and impairs liver regeneration after injury.
The presence of αSMA-positive cells in the proximities of the
senescent cholangiocytes suggests that senescence might have a
role in the development of ﬁbrosis, characteristic of human PSC/
PBC.
After induction, our model exhibits bile duct apoptosis. This
suggests that biliary senescence generates an environment per-
missive for the initiation of apoptotic mechanisms (previously
described as a potential mediator of ductopenia4), but further
investigations are required to investigate the mechanisms behind
this phenomenon.
The presence of senescent cholangiocytes aggravates biliary
disease upon administration of DDC diet and conﬁrms that
senescent cholangiocytes exert a detrimental role in the devel-
opment of biliary disease and regeneration. Senescent cho-
langiocytes affect their microenvironment, altering macrophage
inﬁltration, collagen deposition and impairing biliary functions.
The induction of senescence in cholangiocytes also results in the
establishment of paracrine senescence in the liver parenchyma
through TGFβ-dependent mechanisms. This suggests that the
initial wave of senescence in the bile ducts might spread and
compromise the regenerative ability of the liver parenchyma,
conﬁrmed by the decreased survival of animals subjected to
biliary senescence and 70% PH.
As a role for senescent cholangiocytes in the attraction of
macrophages has been suggested in PBC6, we used an in vitro
model to investigate the interaction between macrophage inﬁl-
tration and senescent cholangiocytes observed in the in vivo
model. The number of senescent cholangiocytes decreases when
co-cultured with BMDM, suggesting that macrophages can target
and eliminate senescent cholangiocytes. These observations pro-
vide a potential mechanism that explains the disappearance of
bile ducts seen in human PSC/PBC4,6. Destruction of biliary
architecture is not present in this model; however, ductopenia is a
late feature in PSC/PBC4,5 and likely occurs over years of injury
and impaired regeneration, which is challenging to simulate in a
mouse model.
Inhibition of TGFβ signalling partially blocks paracrine
senescence effects. Consistently, we have demonstrated that
in vivo partial ablation of the SASP through TGFβ inhibition
decreases paracrine senescence, increases hepatocyte proliferation
and liver function. Furthermore, it appears to decrease ﬁbro-
genesis in our model (although it should be noted that TGFβ
inhibition can also decrease liver ﬁbrosis per se37).
We suggest that senescence may contribute to the development
of biliary disease through complementary mechanisms. First,
through an impaired regenerative response of cholangiocytes38,
unable to compensate biliary damage, and second, through SASP
expression, that can induce paracrine senescence in hepatocytes
(thus diminishing the regenerative capacity of the liver during
injury)11,12, promote collagen deposition and enhance
ﬁbrogenesis34,35.
Overall, we have shown that cellular senescence is likely to be a
driver of biliary injury by affecting the microenvironment,
impairing liver parenchyma regeneration and impairing biliary
function. Importantly, we have found that this pathology can be
speciﬁcally targeted through TGFβ inhibition.
Methods
Clinical material. Human liver biopsies from a clinical series of PSC and PBC cases
(parafﬁn-embedded samples, n= 7 per group) were anonymized and assessed
histologically using H&E by an expert pathologist. Diagnoses were based on clinical
data and conﬁrmed by histology (see Supplementary Table 1). Normal human liver
samples were obtained from autopsy cases from non-hepatic disease with normal
liver histology (n= 7). Informed consent was obtained from the patients for the
tissue to be used in the Tissue Governance Group, College of Medicine and
Veterinary NHS Lothian Public Health Ofﬁce, under project license TGU-LAB-
SR299 approved by the Local Commission for Medical Ethics, University of
Edinburgh.
Animal models. Mice were housed in a speciﬁc pathogen-free environment in
open cages (NKP, M3-sloping front) with Aspen chips as bedding at 21 °C. Mice
were kept under standard conditions with a 14-h day cycle and access to food
(irradiated RM3P) and water ad libitum. Power calculations are not routinely
performed. However, animal numbers were chosen to reﬂect the expected mag-
nitude of response taking into account the variability observed in previous
experiments. Mice were randomly allocated to each experimental group and males/
females are equally distributed. All animal experiments were carried out under
procedural guidelines, severity protocols and within the UK with ethical permission
from the Animal Welfare and Ethical Review Body (AWERB) and the Home Ofﬁce
(UK).
K19CreERT+ and K19CreERT− mice were crossed with Mdm2ﬂox/ﬂox and
R26RtdTomatoLSL mice to generate K19-Mdm2ﬂox/ﬂoxtdTomLSL line (Cre+ and
Cre−). The animals used in this study are C57Bl/6 background, mix of males and
females aged within 8–12 weeks at the start of the experiments.
C57Bl/6 mice were used in some ﬁgures (see as example Supplementary Fig. 10)
as healthy control. C57Bl/6 mice under 1 week of DDC diet were also included as
control of the DDC diet in our model.
OPNiCreERT2+ and OPNiCreERT2−mice were crossed with Mdm2ﬂox/ﬂox and
R26RYFP mice to generate OPN-Mdm2ﬂox/ﬂoxYFP line (Cre+ and Cre−). The
animals used on this study have CD1-enriched background, mix of males and
females aged within 8–12 weeks at the start of the experiments.
K19CreERT and R26RtdTomatoLSL were purchased from Jackson Laboratory.
Fig. 7 Cellular senescence can be transmitted in vitro. Inhibition of TGFβ decreases paracrine senescence. a Experimental scheme; biliary cells were treated
with RAS-conditional media (CM-RAS) and CONTROL-conditional media (CM-Ctrol) for a week. Media is eliminated and cells washed with PBS ﬁve times.
YFP-positive biliary cells (YFP-biliary cells) are then added and after 1 week different markers of senescence in the YFP-biliary cells population were
assessed. b Representative images of the assessed markers of senescence and proliferation (BrdU) in the co-culture of senescent biliary cells (YFP-
negative) and YFP-positive cells. Data is presented as biliary cells treated with CM-STOP and CM-RAS at ﬁnal time point (14 days). Far right, percentage of
each marker in the YFP-biliary cells population. * denotes p < 0.05 (Mean ± SEM). Mann−Whitney test. N= 4 biological replicates. Scale bars= 50 µm. c
Experimental scheme for the use of TGFβ inhibitor (LY-2157299); YFP-biliary cells and different concentrations of LY-2157299 are added to the senescent
biliary cells. After 1 week different markers of senescence in the YFP-biliary cells population were assessed. d Decrease of senescence factors and increase
in proliferation in YFP-biliary cells with increasing concentrations of LY-2157299. * denotes p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (Mean ±
SEM). ANOVA, Sidak’s multiple comparisons test. N= 4 biological replicates
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OPNiCreERT2R26RYFP mouse line was a kind gift by F. Lemaigre and I.
Leclercq, Institut de Recherche Expérimentale et Clinique and Duve Institute
Brussels, Belgium. Mdm2ﬂox/ﬂox mice were generously provided by Professor Gigi
Lozano, Department of Cancer Genetics, University of Texas. All animal
genotyping was outsourced commercially to Transnetyx, Inc (TN, USA) using the
primers stated in Supplementary Table 2.
Further details (ARRIVE guidelines) about the use of the animal models can be
found in Supplementary Note 1.
Induction of the model and recovery of samples. Recombination of loxP sites
was induced with three doses of 4 mg tamoxifen (Sigma) in sunﬂower seed oil
(Sigma) by intraperitoneal injection on alternate days. Mice were killed according to
UK Home Ofﬁce regulations and blood collected by cardiac puncture and cen-
trifuged to collect serum. Livers were perfused in situ with PBS through the portal
vein and harvested. Organs were harvested and either directly frozen at −80 °C or
ﬁxed in 10% formalin (in PBS) for 12 h prior to embedding in parafﬁn blocks.
DDC diet. To induce biliary injury, mice were given 0.1% 3,5-diethoxycarbonyl-
1,4-dihydrocollidine (DDC) mixed with Rat & Mouse No Maintenance (RM1) diet
(Special Diet Services) as previously described39. DDC diet was administered for
7 days, 2 days after last tamoxifen injection. Although the literature describes
prolonged periods of DDC feeding in different mouse models, the
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K19-Mdm2ﬂox/ﬂoxtdTom line only admitted 1 week of DDC diet due to its
C57BL6/J background. This decision takes into consideration restrictions of a
maximum total weight loss of 20%.
70% partial hepatectomy. Brieﬂy, median laparotomy was performed under
isoﬂurane anaesthesia and left lateral and median lobe were removed as previously
described28. To avoid damaging the gallbladder, the ‘three knots’ technique was
performed. Sham-operated mice were subject to laparotomy and brief manipula-
tion of the intestines, but no hepatectomy was performed. Mice were killed at 48 h
and 1 week after surgery.
In vivo use of TGFβR1 antagonists. Galunisertib (LY2157299, Cayman Chemical
Company) was administered at 10 mg/kg twice daily by gavage after the induction
of the model until day 2, when we administered DDC diet as stated. LY2157299
was prepared in 10% polyethylene glycol, 5% DMSO and 85% saline vehicle.
Control mice were administered only with the vehicle (PEG, DMSO, Saline).
Serum analysis. Serum analysis used commercial kits according to the manu-
facturer’s instructions; serum albumin (Alb), bilirubin and alanine transaminase
(ALT) (Alpha Laboratories); aspartate aminotransferase (AST) and alkaline
phosphatase(ALP) (Randox laboratories); Cholesterol (Wako Chemicals GmbH).
All kits were adapted for use on a Cobas Fara centrifugal analyser (Roche
Diagnostics).
Histology. Parafﬁn sections (4 μm) were cut and stained. Antibodies used for
antigen detection in the current study are provided together with method of
antigen retrieval, working dilution and isotype control (Supplementary Table 3).
Immunohistochemistry. For tissue, 100 mM sodium citrate pH 6.0 or 100 mM
Tris-EDTA pH 9.0 were used for antigen retrieval. Sections were blocked for
endogenous peroxidase and alkaline phosphatase activity (Bloxall, Vector), endo-
genous avidin/biotin (Invitrogen) and nonspeciﬁc protein binding (Spring
Bioscience). Primary antibodies were incubated as stated in Supplementary Table 3.
Species-speciﬁc secondary biotinylated antibodies (Vector), Vectastain R.T.U, ABC
reagent (Vector) and DAB chromogen (Dako) were used sequentially to detect the
primary antibody. Sections were counterstained with haematoxylin.
Isotype control is used in the same concentration as the primary antibody. The
sample is then incubated with the secondary antibody and detection reagents.
Immunoﬂuorescence. For tissue, 100 mM sodium citrate pH 6.0 or 100 mM Tris-
EDTA pH 9.0 were used for antigen retrieval. Sections were blocked with protein
block (Spring Bioscience) and incubated using antibodies listed in Supplementary
Table 3. Primary antibodies were detected using ﬂuorescent-conjugated secondary
antibodies (Alexa-488, 555 of 650, Invitrogen). Sections were mounted with DAPI
containing media (DAPI Fluoromount-G, SouthernBiotech).
Isotype control is used in the same concentration as the primary antibody. The
sample is then incubated with the secondary antibody and detection reagents.
TUNEL. Apoptosis was assessed using In Situ Cell Death Detection Kit (Roche)
according to the manufacturers’ instructions. Positive control was performed using
10 units/ml of DNAseI (Qiagen).
Haematoxylin and eosin. Sections were stained routinely and mounted in
ﬂuorescence-free DPX mountant (Sigma).
PicroSirius Red. Sections were stained using picric acid (P6744-1GA), fast green
(F7258-25G) and direct red (365548-25G, all from Sigma Aldrich).
In situ hybridization. In situ mRNA hybridization (ISH) was performed using
RNAscope LS probes for Tgfβ1, Mdm2 and PPIB control (407758, 447648 and
313918; Advanced Cell Diagnostics) as per the manufacturer’s instructions. Images
were acquired and each probe was quantiﬁed in cholangiocytes and hepatocytes,
which are identiﬁed based on their morphology.
In vitro studies. Biliary cells were obtained as previously described and routinely
used in our laboratory29,40. YFP-Biliary cells is a stably transfected GFP biliary cell
line derived in the laboratory29. Prior use in our experiments, YFP-Biliary cells
were cultured with medium supplemented with 3 μg/ml of puromycin (Thermo
Fisher) for 14 days to exclude cells that randomly lose YFP. YFP expression of
stably transfected lines was constantly monitored with ﬂuorescence microscopy.
Biliary cells are cultured in Williams’ E 10% FCS supplemented with 20 mM
HEPES pH 7.5, 17.6 mM NaHCO3, 10 mM nicotinamide, 1 mM sodium pyruvate,
1× ITS, 100 nM dexamethasone, 0.2 mM ascorbic acid, 14 mM glucose 1.4 M, 10 ng/
ml IL-6 10 μg/ml, 10 ng/ml HGF 20 μg/ml, 10 ng/ml EGF 100 μg/ml as previously
described40. All experiments were performed at passage 16–17.
Induction of senescence with conditioned medium. To induce senescence, we
treated biliary cells with conditioned media for a week. For co-culture experiments,
cells were counted, conditioned media eliminated and cells washed with PBS1x ﬁve
times before plating same number of YFP-Biliary cells. For the inhibition of TGFβ
signalling experiment, LY2157299 (Cayman Chemical Company) solubilized in
DMSO was added at the stated concentrations. DMSO was used for controls.
Conditioned media-SASP (CM-SASP) was produced as described in Acosta
et al.12. Brieﬂy, IMR90 ER:RAS cells (2×106) were seeded in a 10 cm dish and
incubated for 7 days with 200 nM 4OHT in DMEM with 0.5% FBS. After
incubation, the conditioned medium (CM) was collected, centrifuged at 5000 × g
and ﬁltered through a 0.2 μm pore ﬁlter. CM was mixed with DMEM 40% FBS in a
proportion of 3 to 1 to generate CM containing 10% FBS. Control conditioned
media (CM-Ctrol) is produced in the same manner from IMR90 ER:STOP cell line.
DDAOG detection of SA β-Galactosidase activity. Cells were sequentially cul-
tured with 100 nM Baﬁlomycin A1 (Sigma) and 100 μM DDAOG (Thermo), 1 and
2 h respectively at 37 °C as previously described41. Cells were then ﬁxed 15 min 4%
paraformaldehyde and permeabilized with 0.2% Triton X-100 for 10 min. Images
were acquired the same day at 647 nM exposure.
5-Bromo-2′-deoxyuridine incorporation. 5-Bromo-2′-deoxyuridine (BrdU)
(Invitrogen) is added to the cells at 3 μg/ml and cultured 3 h at 37 °C. Cells were
ﬁxed in cold Methanol:Acetone (1:1) for 10 min and treated with 2 N HCl 30 min at
RT. Immunoﬂuorescence was routinely performed (Supplementary Table 3).
Nuclear staining was performed with DAPI.
Immunoﬂuorescence for cells. Cells were ﬁxed in cold Methanol:Acetone (1:1)
for 10 min and permeabilized with 0.1% Triton A-100 (Sigma) during 15 min
before immunoﬂuorescence was routinely performed. Antibodies used are listed in
Supplementary Table 3. Nuclear staining was performed with DAPI.
Microscopy and cell counting. Images were acquired using a Nikon Eclipse e600
and Retiga 2000R camera (Q-Imaging, Image Pro premier software) or Perkin
Elmer Operetta high content imaging system. For single-cell quantiﬁcation in
tissue, images were acquired in up to four ﬂuorescent channels at ×20 magniﬁ-
cation, and analysed using Fiji ImageJ or Columbus Image Data Storage and
Analysis System (Perkin Elmer) software depending on the microscope used.
Histological sections were assigned a randomized blinded code prior to
quantiﬁcation by a separate researcher, and the randomization decoded at the time
of the ﬁnal data analysis. Quantiﬁcation of different liver populations from the
images was performed manually on 30 random non-overlapping ﬁelds per mouse
(×200 magniﬁcation).
Ductopenic index was calculated by dividing the number of K19-positive bile
ducts per portal tract. Any ratio below a 0.5 threshold was considered ductopenia42.
Cells were identiﬁed based on DAPI stained-nuclei, morphology and speciﬁc
staining for each population. Illumination correction and background
Fig. 8 Use of TGFβ inhibitors in vivo impairs transmission of paracrine senescence and improves liver function. a Pattern of administration of LY2157299 by
oral gavage after induction of senescence in the K19-Mdm2ﬂox/ﬂoxtdTomLSL model. b Representative images of p21 (red) in cholangiocytes (green) in mice
treated with vehicle, 10 or 20mg/kg of LY2157299. c Percentage of p21-positive cholangiocytes diminishes with the administration of LY2157299. d Total
percentage of p21 diminishes with LY2157299 administration. e Decrease of p27 total number of cells with LY2157299 administration. f Percentage of
tdTom-positive cholangiocytes is not altered. Statistic analysis for c–f * denotes p < 0.05, ** denotes p < 0.01, *** denotes p < 0.001, **** denotes p <
0.0001 (Mean ± SEM). ANOVA, Sidak’s multiple comparisons test (N= 5 per group). g After induction of senescence in cholangiocytes, LY2157299 was
administered to the mice by oral gavage. Then DDC diet was administered to the mice for 1 week. Experimental groups for this experiment include:
Senescence+Vehicle+DDC (Veh, N= 5) and Senescence+ Inhibitor+DDC (Inh, N= 5). h Decrease in serum transaminase levels. i Increased levels of
Ki67-positive cholangiocytes with the use of LY2157299. Far right, quantiﬁcation. j Increased levels of total Ki67 per ﬁeld with LY2157299. k Trend to
decrease (p= 0.0952) of total p27 levels. l Left, decreased expression of p21-positive hepatocytes. Right, decreased expression of p16-positive
hepatocytes. m Decreased collagen deposition with the use of LY2157299. n Trend to decrease (p= 0.1508) of total number of F4/80 macrophages per
ﬁeld. * denotes p < 0.05, ** p < 0.01 (Mean ± SEM). Student’s ttest. Scale bars= 50 µm
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normalization was performed using the sliding parabola module. For each
experiment identical thresholds were used in all images for assigning nuclei to a
speciﬁc population.
For pixel analysis, ImageProPremier software was used to select regions of
positivity and automatically analysed using a macro-instruction. Results are
expressed as the mean percentage of positive pixels per ﬁeld. PiSR analysis used an
AxioScan Z.1 (Zeiss) to acquire tiled images at ×20 magniﬁcation. Images were
then analysed using a standard colour threshold in Fiji Image J.
DAPI, Alexaﬂuor 488, and 555 were detected using band paths of 415–480,
495–540 and 561–682 nm for 405, 488 543 nm lasers respectively. All scale bars
denote 50 μm.
Isolation of hepatocytes. Mice were killed and their livers were perfused in situ
with Liver Perfusion Medium (Gibco) and Liver Digest Medium (Gibco). The liver
was then disrupted to yield a cell suspension, ﬁltered through a 50 μm ﬁlter (BD
Biosciences) and hepatocytes were pelleted by centrifugation at 135 × g 1 min.
Hepatocytes were then puriﬁed as previously described43. Brieﬂy, cells were
underlayered with 1.06, 1.08 and 1.12 g/ml Percoll (Sigma) in PBS. The 1.08 mg/ml
was spiked with phenol red to aid visualization. Cells were spun at 750 × g 20 min.
Fraction between the 1.08 and 1.12 mg/ml Percoll layers was harvested, puriﬁed
again and transferred to Trizol (Life Technologies). Routinely, cells with hepatocyte
morphology and expression of CYP2D6 (marker of hepatocellular differentiation)
were obtained at over 99% purity29.
Isolation of bile ducts. Bile duct isolation was performed as previously descri-
bed44. Brieﬂy, livers were perfused with saline, dissected down to approximately
2–4 mm3 portions and covered with a mix of Collagenase-Dispase in 2%FCS
Advanced DMEMF/12 (Thermo Fisher). This mix was incubated at 37 °C 1 h and
individual ductular structures were manually picked up, cleaned with 5%FCS
DMEM (Thermo Fisher) and transferred to Trizol.
Isolation of BMDM and co-culture with senescent biliary cells. BMDM were
isolated as previously described45, and stained with 647-CellMask Deep Red
Plasma membrane stain (ThermoFisher) following the manufacturer’s instructions.
Biliary cells were treated with CM-SASP for 1 week and washed with PBS1x ﬁve
times. Number of cells were counted and the same ratio of pre-stained 647-BMDM
was added. Both populations were cultured for 72 h.
Immunoblotting. Ductular structures were manually picked up, cleaned with 5%
FCS DMEM and protein extracted with RIPA (Sigma) according to the manu-
facturer’s instructions. Protein content was quantiﬁed using a BSA standard and
Pierce reagent before being resolved using SDS/PAGE and blotted onto nitro-
cellulose membrane. Membranes were blocked with 5% BSA on T-PBS during 1 h
at room temperature. Membranes were incubated at 4 °C overnight with primary
antibody (mouse anti-β actin (Sigma), rabbit anti-p-Smad2 (Ser465/567)/Smad3
(Ser 423/4225) (Cell Signalling) or rabbit anti-NF-kB p65 (Cell Signalling)).
Appropriate HRP-labelled secondary antibodies were used (Dako or CST) and
signal detected with ECL reagent (Amersham). In order to use the same membrane
with different antibodies, stripping was performed with mild stripping buffer
during 10 min at room temperature. Membrane was blocked again with 5% BSA on
T-PBS during 1 h and re-incubated with the desired antibody overnight. All
uncropped western blots can be found in Supplementary Figure 14.
RNA isolation followed by RT-qPCR and gene expression analysis. RNA was
isolated from bile ducts and hepatocytes using Trizol (Life Technologies) and
puriﬁed using RNease RNA extraction kit (Qiagen) according to the manu-
facturer’s instructions. RNA concentration and quality was assessed using a
Nanodrop spectrophotometer (Thermo-Fisher). Reverse transcription was per-
formed using QuantiTect Reverse transcription kit (Qiagen). Real time-QPCR was
performed on a LightCycler 480 II (Roche) with commercial primers from Qiagen’s
QuantiTect (stated in Supplementary Table 4). Each gene expression was assessed
with its own standard curve and normalized using Peptidylprolyl Isomerase A
(PPIA) as housekeeping gene. Samples were run in triplicate.
Statistical analysis. A minimum of four mice were included per experimental
group. For cell culture experiments, a minimum of four independent biological
replicates were performed.
Prism software version 5.0a (GraphPad Software, Inc) was used for all statistical
analyses. Normal distribution of data was determined using D’Agostino and
Pearson omnibus normality test with Welch’s correction if variances differed (F
test). For parametric data, data signiﬁcance was analysed using a two-tailed
unpaired Student's t-test. Non-parametric data was analysed using Mann
−Whitney test. In cases where more than two groups were being compared, then a
one-way ANOVA (with Bonferroni correction) was used. Survival curves are
calculated using Log-Rank comparison (Mantel−Cox test) and Gehan−Breslow
−Wilcoxon test.
Statistical signiﬁcance was assumed at p < 0.05. Data is presented as mean ±
standard error of the mean (SEM). N refers to biological replicates.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its supplementary information ﬁles or
from the corresponding author upon reasonable request. No data sets were gen-
erated or analysed during the current study.
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